Bextra® Side Effects
Bextra® is part of a class of non-steroidal anti-inflammatory drugs (NSAIDs) that includes VIOXX® and Celebrex®. Known as COX-2 inhibitors, these medications were intended to treat the symptoms of arthritis, while reducing the risk of acquiring gastrointestinal problems associated with other NSAIDs.
Bextra® Side Effects
Recent studies have reported some dangerous side effects connected with Bextra® use. Patients who take Bextra® face an increased risk of cardiovascular events. Additionally, there have been reports of serious skin conditions, including cases of Stevens-Johnson syndrome and toxic epidermal necrolysis. Other side effects include:
- Stomach ulcers and gastrointestinal bleeding
- Indigestion
- Upper respiratory infection
- Nausea
- Diarrhea
- Sinus inflammation
FDA Recall
On April 7, 2005, the FDA asked Pfizer, the manufacturer of Bextra®, to voluntarily recall the arthritis drug. The agency determined that the risk of cardiovascular problems is no greater with Bextra® than with other COX-2 inhibitors, but that the increased potential for skin reactions warranted its removal from the market.
Speak to a Bextra® Attorney
If you or a loved one has been harmed by Bextra® use, you are encouraged to contact one of the personal injury attorneys in the LawyerShop directory to arrange an evaluation of your potential case.